Applied Genetic Technologies reported $-17088000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alimera Sciences ALIM:US $ -4.35M 10.06M
Applied Genetic Technologies AGTC:US $ -17.09M 2.8M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Celldex Therapeutics CLDX:US $ -20.68M 7.31M
Cti Biopharma CTIC:US $ -24.18M 4.5M
Insmed INSM:US $ -115292000 1.41M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Life Technologies LIFE:US $ -7.67M 2.72M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M